Prognostic role of eIF2α protein in metastatic renal cell cancer patients
Based on these results, we suggest that eIF2α may serve as a novel biomarker to predict survival and treatment response in metastatic RCC patients.
Authors
- Ahmet Dirican (ORCID: https://orcid.org/0000-0001-6992-9289)
- Bilgin Demir (ORCID: https://orcid.org/0000-0003-4380-9419)
- Atike Pınar Erdoğan (ORCID: https://orcid.org/0000-0003-4859-7574)
- Kutsal Yörükoğlu (ORCID: https://orcid.org/0000-0002-4099-0905)
- Nil Çulhacı (ORCID: https://orcid.org/0000-0001-7181-4675)
- Nalan Neşe
- Esin Oktay (ORCID: https://orcid.org/0000-0002-5974-6339)
- Ferhat Ekinci (ORCID: https://orcid.org/0000-0002-9317-942X)
- Hanife Seda Mavili (ORCID: https://orcid.org/0000-0003-3741-8489)
- Burçin Tuna (ORCID: https://orcid.org/0000-0002-4195-5167)
- Mehmet Uzun (ORCID: https://orcid.org/0000-0003-2999-489X)
- Aziz Karaoğlu (ORCID: https://orcid.org/0000-0001-5500-156X)
Institutions
- Izmir University (TR)
- Manisa Celal Bayar University (TR)
- Dokuz Eylül University (TR)
- Acıbadem University (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Adnan Menderes University (TR)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1007/s12672-025-02916-2
- Citations
- 1
- Primary Topic
- Endoplasmic Reticulum Stress and Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.15